商品簡介
This volume co-published in partnership with The Breast Cancer Research Foundation, provides a comprehensive review of novel biomarkers that can be used in the continuum of breast cancer. These include genetic, epigenetic, pharmacogenetic, and other biomarkers that can be used to determine risk of breast cancer, or, once diagnoses, breast cancer prognosis. Other biomarkers will be used to determine response to local and systemic treatment strategies. The book is written by leading experts in a variety of topics who will provide not only a comprehensive review but also a glimpse into the future of breast cancer research, potential therapeutics, and prevention.
作者簡介
Dr. Vered Stearns is the Co-Director of the Breast Cancer Program at the Sidney Kimmel Comprehensive Cancer Center, Professor of Oncology, and Breast Cancer Research Chair in Oncology and Johns Hopkins School of Medicine. Dr. Stearns is an expert in novel drug investigation—her focus is also on surrogate markers that may influence risk of breast cancer and the effectiveness of drugs. She has published over 150 scientific publications and has received over 5,368 citations in her career.
